210 related articles for article (PubMed ID: 2120029)
1. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
Servant D; Bailly D; Le Seac'h H; Parquet PJ
Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
[TBL] [Abstract][Full Text] [Related]
2. Treatment of depersonalization with serotonin reuptake blockers.
Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
5. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
Greist JH
J Clin Psychiatry; 1990 Aug; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
[TBL] [Abstract][Full Text] [Related]
6. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
Murphy DL; Pigott TA
J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
[TBL] [Abstract][Full Text] [Related]
7. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
8. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
Trabert W; Hohagen F; Winkelmann G; Berger M
Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
[TBL] [Abstract][Full Text] [Related]
9. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
[TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine as an antiobsessional agent.
Goodman WK; Price LH; Rasmussen SA; Heninger GR; Charney DS
Psychopharmacol Bull; 1989; 25(1):31-5. PubMed ID: 2505302
[TBL] [Abstract][Full Text] [Related]
11. Fluvoxamine in the treatment of panic disorder with obsessive-compulsive symptoms.
Servant D; Bailly D; Parquet PJ
Am J Psychiatry; 1988 Sep; 145(9):1174-5. PubMed ID: 3137830
[No Abstract] [Full Text] [Related]
12. [The role of drugs in the treatment of obsessive-compulsive disorders].
den Boer JA; Westenberg HG
Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
[No Abstract] [Full Text] [Related]
13. Obsessive-compulsive symptoms in patients with panic disorder.
Torres AR; Dedomenico AM; Crepaldi AL; Miguel EC
Compr Psychiatry; 2004; 45(3):219-24. PubMed ID: 15124153
[TBL] [Abstract][Full Text] [Related]
14. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluvoxamine on panic disorder.
Hoehn-Saric R; McLeod DR; Hipsley PA
J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
[TBL] [Abstract][Full Text] [Related]
16. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
Spiegel DA; Saeed SA; Bruce TJ
J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine treatment of obsessive-compulsive disorder.
Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
[TBL] [Abstract][Full Text] [Related]
18. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
